| Year |
Title |
Altmetric |
| 2020
|
The role of metabolic plasticity in blood and brain stem cell pathophysiology.
Cancer Research.
80:5-16.
2020
|
|
| 2019
|
Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.
Glia.
67:2424-2439.
2019
|
|
| 2019
|
SOD2 acetylation and deacetylation: Another tale of Jekyll and Hyde in cancer
2019
|
|
| 2019
|
Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells.
Journal of Ovarian Research.
12.
2019
|
|
| 2019
|
HPAanalyze: An R package that facilitates the retrieval and analysis of the Human Protein Atlas data.
BMC Bioinformatics.
20.
2019
|
|
| 2019
|
Anti-cancer effects of the HuR inhibitor, MS-444, in malignant glioma cells.
Cancer Biology and Therapy.
20:979-988.
2019
|
|
| 2019
|
BEERE: a web server for biomedical entity expansion, ranking and explorations.
Nucleic Acids Research.
47:W578-W586.
2019
|
|
| 2019
|
Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma.
International Journal of Oncology.
54:2039-2053.
2019
|
|
| 2019
|
New quantitative approach reveals heterogeneity in mitochondrial structure–function relations in tumor-initiating cells.
Journal of Cell Science.
132.
2019
|
|
| 2019
|
Chromodomain Helicase DNA-Binding Protein 7 Is Suppressed in the Perinecrotic/Ischemic Microenvironment and Is a Novel Regulator of Glioblastoma Angiogenesis.
STEM CELLS.
37:453-462.
2019
|
|
| 2019
|
Recasting the Cancer Stem Cell Hypothesis: Unification Using a Continuum Model of Microenvironmental Forces.
Current Stem Cell Reports.
5:22-30.
2019
|
|
| 2018
|
UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.
Journal of Neuro-Oncology.
140:209-224.
2018
|
|
| 2018
|
IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2/IGF-1R signaling 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 11 Medical and Health Sciences 1103 Clinical Sciences.
Cell Communication and Signaling.
16.
2018
|
|
| 2018
|
Identification of Compounds That Decrease Glioblastoma Growth and Glucose Uptake in Vitro.
ACS Chemical Biology.
13:2048-2057.
2018
|
|
| 2018
|
Reactive species balance via GTP cyclohydrolase i regulates glioblastoma growth and tumor initiating cell maintenance.
Neuro-Oncology.
20:1055-1067.
2018
|
|
| 2018
|
Kinomic profiling of glioblastoma cells reveals PLCG1 as a target in restricted glucose.
Biomarker Research.
6.
2018
|
|
| 2018
|
The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1 signaling.
Journal of Biological Chemistry.
293:5659-5667.
2018
|
|
| 2018
|
The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells
2018
|
|
| 2017
|
Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo..
JCI insight.
2.
2017
|
|
| 2017
|
NOS Expression and NO Function in Glioma and Implications for Patient Therapies.
Antioxidants and Redox Signaling.
26:986-999.
2017
|
|
| 2017
|
Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells.
Journal of Neuro-Oncology.
132:219-229.
2017
|
|
| 2017
|
Modeling Physiologic Microenvironments in Three-Dimensional Microtumors Maintains Brain Tumor Initiating Cells..
Journal of cancer stem cell research.
5.
2017
|
|
| 2017
|
The Arf activator GBF1 localizes to plasma membrane sites involved in cell adhesion and motility..
Cellular Logistics.
7:e1308900.
2017
|
|
| 2016
|
RBIO-05. miRNAs THAT CONFER GLIOBLASTOMA RESISTANCE: IS THE COMBINATION MERELY A SUM OF THE PARTS?.
Neuro-Oncology.
18:vi173-vi173.
2016
|
|
| 2016
|
TMOD-18. THREE-DIMENSIONAL MICROTUMORS IN PHYSIOLOGIC MICROENVIRONMENTS MAINTAIN BRAIN TUMOR INITIATING CELLS.
Neuro-Oncology.
18:vi210-vi210.
2016
|
|
| 2016
|
Novel Retinoid UAB30 Decreases Tumorigenicity and Cancer Stem Cell Maintenance in Human Neuroblastoma Patient-Derived Xenografts.
Journal of The American College of Surgeons.
223:e160-e161.
2016
|
|
| 2016
|
334 A Functional Screen Identifies miRNAs that Induce Radioresistance in Glioblastomas.
Neurosurgery.
63:197-198.
2016
|
|
| 2016
|
MB-41INTRAVENTRICULAR ONCOLYTIC ENGINEERED HERPES SIMPLEX VIRUS PROLONGS SURVIVAL AND REDUCES SPINAL METASTASES IN MICE BEARING HUMAN GROUP 3 MEDULLOBLASTOMA.
Neuro-Oncology.
18:iii106.1-iii106.
2016
|
|
| 2016
|
Metabolic, autophagic, and mitophagic activities in cancer initiation and progression.
Biomedical Journal.
39:98-106.
2016
|
|
| 2015
|
Kinome-wide shRNA screen identifies the receptor tyrosine kinase AXL as a key regulator for mesenchymal glioblastoma stem-like cells.
Stem Cell Reports.
4:899-913.
2015
|
|
| 2015
|
Acquisition of meiotic DNA repair regulators maintain genome stability in glioblastoma.
Cell Death and Disease.
6.
2015
|
|
| 2015
|
A new mitochondrial pool of cyclin E, regulated by Drp1, is linked to cell-density-dependent cell proliferation.
Journal of Cell Science.
128:4171-4182.
2015
|
|
| 2015
|
Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.
Neuro-Oncology.
17:361-371.
2015
|
|
| 2014
|
A functional screen identifies miRs that induce radioresistance in glioblastomas
2014
|
|
| 2014
|
Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells.
Cell Death and Differentiation.
21:258-269.
2014
|
|
| 2014
|
Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy.
Genes and Development.
28:1085-1100.
2014
|
|
| 2014
|
High-throughput flow cytometry screening reveals a role for junctional adhesion molecule a as a cancer stem cell maintenance factor.
Cell Reports.
6:117-129.
2014
|
|
| 2014
|
Method for Efficient Transduction of Cancer Stem Cells..
Journal of cancer stem cell research.
2.
2014
|
|
| 2014
|
Microenvironmental Variables Must Influence Intrinsic Phenotypic Parameters of Cancer Stem Cells to Affect Tumourigenicity.
PLoS Computational Biology.
10.
2014
|
|
| 2014
|
Phage display discovery of novel molecular targets in glioblastoma- initiating cells.
Cell Death and Differentiation.
21:1325-1339.
2014
|
|
| 2013
|
Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A.
Journal of Experimental Medicine.
210:2851-2872.
2013
|
|
| 2013
|
Microenvironmental variables must influence intrinsic phenotypic parameters of cancer stem cells to affect tumourigenicity
2013
|
|
| 2013
|
Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake.
Nature Neuroscience.
16:1373-1382.
2013
|
|
| 2013
|
Aptamer identification of brain tumor-initiating cells.
Cancer Research.
73:4923-4936.
2013
|
|
| 2013
|
Multiplex Flow Cytometry Barcoding and Antibody Arrays Identify Surface Antigen Profiles of Primary and Metastatic Colon Cancer Cell Lines.
PLoS ONE.
8.
2013
|
|
| 2013
|
Intrinsic cell factors that influence tumourigenicity in cancer stem cells - towards hallmarks of cancer stem cells.
CoRR.
abs/1301.3934.
2013
|
|
| 2012
|
Laminin alpha 2 enables glioblastoma stem cell growth.
Annals of Neurology.
72:766-778.
2012
|
|
| 2012
|
The quest for self-identity: Not all cancer stem cells are the same.
Clinical Cancer Research.
18:3495-3498.
2012
|
|
| 2012
|
Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity.
Genes and Development.
26:1247-1262.
2012
|
|
| 2012
|
Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential.
Cell Death and Differentiation.
19:428-439.
2012
|
|
| 2011
|
Twisted tango: Brain tumor neurovascular interactions.
Nature Neuroscience.
14:1375-1381.
2011
|
|
| 2011
|
Direct In Vivo evidence for tumor propagation by glioblastoma cancer stem cells.
PLoS ONE.
6.
2011
|
|
| 2011
|
Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions.
Cell Death and Disease.
2.
2011
|
|
| 2011
|
Glioma stem cell maintenance: The role of the microenvironment.
Current Pharmaceutical Design.
17:2386-2401.
2011
|
|
| 2011
|
Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2.
Cell.
146:53-66.
2011
|
|
| 2011
|
Acidic stress promotes a glioma stem cell phenotype.
Cell Death and Differentiation.
18:829-840.
2011
|
|
| 2011
|
Nonreceptor Tyrosine Kinase BMX Maintains Self-Renewal and Tumorigenic Potential of Glioblastoma Stem Cells by Activating STAT3.
Cancer Cell.
19:498-511.
2011
|
|
| 2011
|
Molecular targeting of neural cancer stem cells: TTAGGG, you're it!.
Clinical Cancer Research.
17:3-5.
2011
|
|
| 2010
|
Erythropoietin receptor signaling through STAT3 Is required for glioma stem cell maintenance.
Genes and Cancer.
1:50-61.
2010
|
|
| 2010
|
Integrin Alpha 6 regulates glioblastoma stem cells.
Cell Stem Cell.
6:421-432.
2010
|
|
| 2010
|
Hypoxia inducible factors in cancer stem cells.
British Journal of Cancer.
102:789-795.
2010
|
|
| 2010
|
Targeting A20 decreases glioma stem cell survival and tumor growth.
PLoS Biology.
8.
2010
|
|
| 2010
|
Notch promotes radioresistance of glioma stem cells.
STEM CELLS.
28:17-28.
2010
|
|
| 2009
|
The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype.
Cell Cycle.
8:3274-3284.
2009
|
|
| 2009
|
Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth.
STEM CELLS.
27:2393-2404.
2009
|
|
| 2009
|
NDRG4 is required for cell cycle progression and survival in glioblastoma cells.
Journal of Biological Chemistry.
284:25160-25169.
2009
|
|
| 2009
|
Turning cancer stem cells inside out: An exploration of glioma stem cells signalling pathways.
Journal of Biological Chemistry.
284:16705-16709.
2009
|
|
| 2009
|
Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells.
Cancer Cell.
15:501-513.
2009
|
|
| 2008
|
Brain cancer stem cells display preferential sensitivity to Akt inhibition.
STEM CELLS.
26:3027-3036.
2008
|
|
| 2008
|
c-Myc is required for maintenance of glioma cancer stem cells.
PLoS ONE.
3.
2008
|
|
| 2008
|
Targeting cancer stem cells through L1CAM suppresses glioma growth.
Cancer Research.
68:6043-6048.
2008
|
|
| 2007
|
The combination of novel low molecular weight inhibitors of RAF (LBT613) and target of rapamycin (RAD001) decreases glioma proliferation and invasion.
Molecular Cancer Therapeutics.
6:2449-2457.
2007
|
|
| 2007
|
Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases.
Oncogene.
26:4084-4094.
2007
|
|
| 2007
|
A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
Molecular Carcinogenesis.
46:488-496.
2007
|
|
| 2006
|
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
Nature.
444:756-760.
2006
|
|
| 2006
|
APOE4-VLDL inhibits the HDL-activated phosphatidylinositol 3-kinase/Akt pathway via the phosphoinositol phosphatase SHIP2.
Circulation Research.
99:829-836.
2006
|
|
| 2006
|
AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma.
Cancer Research.
66:8722-8730.
2006
|
|
| 2006
|
Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor.
Cancer Research.
66:7843-7848.
2006
|
|
| 2006
|
A novel low molecular weight inhibitor of focal adhesion kinase and insulin-like growth factor-1 receptor, TAE226, inhibits glioma growth..
Journal of Clinical Oncology.
24:11505.
2006
|
|
| 2005
|
Loss of phosphatase and tensin homologue increases transforming growth factor β-mediated invasion with enhanced SMAD3 transcriptional activity.
Cancer Research.
65:11276-11281.
2005
|
|
| 2005
|
Loss of Smad3-mediated negative regulation of Runx2 activity leads to an alteration in cell fate determination.
Molecular and Cellular Biology.
25:9460-9468.
2005
|
|
| 2004
|
SB-431542, a small molecule transforming growth factor-β-receptor antagonist, inhibits human glioma cell line proliferation and motility.
Molecular Cancer Therapeutics.
3:737-745.
2004
|
|
| 2004
|
Selective Deficiency of the "Bone-related" Runx2-II Unexpectedly Preserves Osteoblast-mediated Skeletogenesis.
Journal of Biological Chemistry.
279:20307-20313.
2004
|
|
| 2003
|
Methyl parathion: A review of health effects
2003
|
|
| 2001
|
An Essential Role for Mad Homology Domain 1 in the Association of Smad3 with Histone Deacetylase Activity.
Journal of Biological Chemistry.
276:22595-22603.
2001
|
|
| 2001
|
Transforming growth factor-β signaling in cancer.
Microscopy Research and Technique.
52:363-373.
2001
|
|
| 2001
|
The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis.
Journal of Bone and Mineral Research.
16:1754-1764.
2001
|
|
| 1999
|
Targeted disruption of Smad3 reveals an essential role in transforming growth factor β-mediated signal transduction.
Molecular and Cellular Biology.
19:2495-2504.
1999
|
|
